Pharma Deals Review, Vol 2002, No 26 (2002)

Font Size:  Small  Medium  Large

VaxGen Amends Agreement with Genentech for AIDSVAX

Business Review Editor

Abstract


VaxGen and Genentech amended their license and supply agreement, to facilitate the commercialization of AIDS vaccine by VaxGen. Genentech will maintain its option to market and sell AIDSVAX in North America.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.